Firebrick Pharma Limited (AU:FRE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited has announced the cessation of Richard Treagus as a director of the company effective September 30, 2024. Additionally, a disclosure was made regarding the interest of 100,000 options at $0.42 expiring on November 23, 2026, held beneficially by Ms. Karen E Treagus under the Treagus Family Account. The notice underscores the importance of transparency in the management changes and interests within the company.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.